ImmunoACT shared on X:
“Early referral can make a meaningful difference in the CAR-T journey.
Dr. Anusha Swaminathan shares why timely evaluation matters in relapsed or refractory B-cell malignancies – allowing time for assessment, planning and risk management.”
Why Early Referral Is Becoming Central to CAR-T Outcomes in India
Other articles about CAR-T on OncoDaily.